A recent discussion on X pointed out an uncomfortable pattern: the diagnostic thresholds for common conditions keep shifting, instantly turning large numbers of previously healthy people into patients—and reliable customers for the pharmaceutical industry. Hypertension, prediabetes, and diabetes were the examples cited. Those cases are well documented. They are also part of a larger process that has increasingly treated normal aging itself as a collection of medical deficienc